SAN DIEGO, Feb. 3 BD Diagnostics, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), today announced the launch of the Be a Flu Fighter initiative, aimed at increasing awareness and prevention of influenza. Recognizing that schools and hospitals are important centers for health-related information, the Be a Flu Fighter initiative is designed to communicate that everyone can help prevent the spread of flu by taking just a few simple precautions.
BD has designed the Be a Flu Fighter initiative to enhance the ability of healthcare professionals at schools, hospitals, laboratories and other public/private settings to help slow the predicted, rapid spread of influenza by promoting good hygiene, vaccination and other flu prevention strategies. With straightforward, accessible language and graphics, the complimentary, printer-friendly materials can be easily downloaded from www.bd.com/ds/flufighter. The BD site also provides hospitals and laboratories with informational materials designed to help professionals properly obtain and handle specimens for flu diagnosis.
"As a world leader in healthcare, BD is pleased to provide these much-needed resources. Our role goes beyond providing quality products, and includes enabling healthcare professionals to effectively spread the word about practices that can lead to better prevention, diagnosis and therapy for infectious diseases, such as influenza," said Tobi Karchmer, MD, Medical Director, BD Diagnostics.
BD is a leading global medical technology company that develops, manufactures and sells medical devices, instrument systems and reagents. The Company is dedicated to improving people's health throughout the world. BD is focused on improving drug delivery, enhancing the quality and speed of diagnosing infectious diseases and cancers, and advancing research, discovery, and production of new drugs and vaccines. BD's capabilities are instrumental in combating many of the world's most pressing diseases. Founded in 1897 and headquartered in Franklin Lakes, New Jersey, BD employs approximately 29,000 associates in approximately 50 countries throughout the world. The Company serves healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry, and the general public. For more information, please visit www.bd.com.
SOURCE BD-Becton Dickinson